1. Home
  2. IQV vs VRSK Comparison

IQV vs VRSK Comparison

Compare IQV & VRSK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IQV
  • VRSK
  • Stock Information
  • Founded
  • IQV 1982
  • VRSK 1971
  • Country
  • IQV United States
  • VRSK United States
  • Employees
  • IQV N/A
  • VRSK N/A
  • Industry
  • IQV Biotechnology: Commercial Physical & Biological Resarch
  • VRSK Business Services
  • Sector
  • IQV Health Care
  • VRSK Consumer Discretionary
  • Exchange
  • IQV Nasdaq
  • VRSK Nasdaq
  • Market Cap
  • IQV 38.1B
  • VRSK 39.7B
  • IPO Year
  • IQV 2013
  • VRSK 2009
  • Fundamental
  • Price
  • IQV $190.88
  • VRSK $275.56
  • Analyst Decision
  • IQV Strong Buy
  • VRSK Hold
  • Analyst Count
  • IQV 16
  • VRSK 11
  • Target Price
  • IQV $256.27
  • VRSK $287.09
  • AVG Volume (30 Days)
  • IQV 1.5M
  • VRSK 659.3K
  • Earning Date
  • IQV 02-12-2025
  • VRSK 10-30-2024
  • Dividend Yield
  • IQV N/A
  • VRSK 0.56%
  • EPS Growth
  • IQV 27.98
  • VRSK 92.59
  • EPS
  • IQV 7.62
  • VRSK 6.41
  • Revenue
  • IQV $15,315,000,000.00
  • VRSK $2,823,300,000.00
  • Revenue This Year
  • IQV $3.66
  • VRSK $9.53
  • Revenue Next Year
  • IQV $4.86
  • VRSK $7.52
  • P/E Ratio
  • IQV $25.21
  • VRSK $43.27
  • Revenue Growth
  • IQV 3.10
  • VRSK 7.16
  • 52 Week Low
  • IQV $187.62
  • VRSK $217.34
  • 52 Week High
  • IQV $261.73
  • VRSK $296.58
  • Technical
  • Relative Strength Index (RSI)
  • IQV 32.51
  • VRSK 34.97
  • Support Level
  • IQV $198.54
  • VRSK $281.38
  • Resistance Level
  • IQV $201.00
  • VRSK $284.70
  • Average True Range (ATR)
  • IQV 4.94
  • VRSK 4.67
  • MACD
  • IQV -0.13
  • VRSK -1.99
  • Stochastic Oscillator
  • IQV 0.42
  • VRSK 0.34

About IQV IQVIA Holdings Inc.

IQVIA is the result of the 2016 merger of Quintiles, a leading global contract research organization, and IMS Health, a leading healthcare data and analytics provider. The research and development segment focuses primarily on providing outsourced late-stage clinical trials for pharmaceutical, device, and diagnostic firms. The technology and analytics segment provides aggregated information and technology services to clients in the healthcare industry, including pharmaceutical companies, providers, payers, and policymakers, as well as data and analytics capabilities for clinical trials, including virtual trials. The company also has a small contract sales business.

About VRSK Verisk Analytics Inc.

Verisk Analytics is the leading provider of statistical, actuarial, and underwriting data for the United States' property and casualty insurance industry. Verisk leverages a vast contributory database and proprietary data assets to develop analytical tools helping insurance providers to better assess and price risk, achieve operational efficiency and optimize claim settlement processes. While Verisk also offers tools to quantify costs after loss events occur and to detect fraudulent activity, it is expanding into adjacent markets of life insurance, marketing, and non-US operations.

Share on Social Networks: